Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTracsis Regulatory News (TRCS)

Share Price Information for Tracsis (TRCS)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -5.00 (-1.52%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £96.78m
TRCS Live PriceLast checked at - London Stock Exchange

Intraday Tracsis Share Chart

Director/PDMR Shareholding

17 Jul 2014 07:54

RNS Number : 5781M
Tracsis PLC
17 July 2014
 



 

Tracsis plc

 

("Tracsis" or the "Company")

 

Directors Dealing - Exercise of Options

 

Tracsis announces that it received on 16 July 2014, notice of exercise of options from the following Directors:

 

John McArthur, Chief Executive Officer, exercised 140,000 options at an exercise price of 52p per share from a share option agreement dated 2009. No shares were sold in order to satisfy exercise costs. As a result of this, Mr McArthur's interests in the company increased to 1,112,474 representing 4.2% of the total voting rights of the Company.

 

Max Cawthra, Finance Director, exercised 75,000 options at an exercise price of 49.5p per share from a share option agreement dated 2011. In order to satisfy exercise costs 25,000 shares were subsequently disposed at a price of £3.11. As a result of this transaction, Mr Cawthra's interests in the company increased from 4,000 to 54,000 representing 0.2% of the total voting rights of the Company.

 

Charles Winward, a Non-Executive Director exercised 87,517 options at an exercise price of 40p per share from a share option agreement dated 2007. In order to satisfy exercise costs, income tax, national insurance and other liabilities arising 57,246 shares were subsequently disposed at a price of £3.11. As a result of this transaction Mr Winward's interests in the company will increase from 56,500 to 86,771 representing 0.3% of the total voting rights of the Company.

 

A summary of these transactions and resulting Directors' holdings in Tracsis is as follows:

 

Share holding prior to exercise

Option holding prior to exercise

Options exercised today

Shares sold today

Resulting Share

Holding

% of issued share capital

Non-Executive Directors

Chris Cole (Chair)

-

-

-

-

-

-

Sean Lippell

-

50,000

-

-

-

-

John Nelson

230,824

25,000

-

-

230,824

0.9%

Charles Winward

56,500

137,517

87,517

(57,246)

86,771

0.3%

Executive Directors

Max Cawthra

4,000

235,162

75,000

(25,000)

54,000

0.2%

John McArthur

972,474

240,000

140,000

-

1,112,474

4.2%

Total Interest

1,263,798

687,679

302,517

(82,246)

1,484,069

5.6%

 

 

Accordingly, the Company has today issued 302,517 ordinary shares in the Company "new ordinary shares". Application has been made for the new ordinary shares to be admitted to trading on AIM and dealings are expected to commence on 22 July 2014.

 

Following the issue of the new shares, the number of Ordinary Shares in issue will increase to 26,258,114. For the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules ("DTRs"), the issued ordinary share capital of the Company following this allotment consists of 26,258,114 Shares with voting rights attached (one vote per Share). There are no shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Tracsis under the DTRs.

 

 

For more information please contact:

 

John McArthur/Max Cawthra, Tracsis plc

 

Tel: 0845 125 9162

Katy Mitchell, WH Ireland Limited

Tel: 0161 832 2174

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGMNVNFGDZG
Date   Source Headline
1st Mar 20197:00 amRNSTotal Voting Rights
28th Feb 20197:00 amRNSListing Application
28th Feb 20197:00 amRNSBlock Listing Return
14th Feb 20199:42 amRNSHolding(s) in Company
4th Feb 20195:50 pmRNSHolding(s) in Company
4th Feb 20197:00 amRNSTotal Voting Rights
23rd Jan 20192:39 pmRNSResult of AGM
17th Jan 20197:00 amRNSCompletion of Acquisition
16th Jan 20197:38 amRNSCompletion of Acquisition
7th Jan 20197:00 amRNSDirectorate Change
3rd Jan 20197:00 amRNSContract Win
2nd Jan 20199:47 amRNSTotal Voting Rights
30th Nov 20187:00 amRNSTotal Voting Rights
8th Nov 20187:00 amRNSFinal Results
1st Nov 20187:00 amRNSDirectorate Changes
31st Oct 20187:00 amRNSTotal Voting Rights
30th Oct 20187:00 amRNSSignificant Contract Win
25th Oct 20187:00 amRNSNotice of Results
28th Sep 20189:19 amRNSTotal Voting Rights
31st Aug 20187:00 amRNSBlock Listing Return
31st Aug 20187:00 amRNSTotal Voting Rights
21st Aug 20187:00 amRNSTrading Update
2nd Aug 20189:57 amRNSTotal Voting Rights
23rd Jul 20183:47 pmRNSHolding(s) in Company
2nd Jul 20188:42 amRNSTotal Voting Rights
26th Jun 20189:21 amRNSHolding(s) in Company
1st Jun 201810:16 amRNSTotal Voting Rights
21st May 20183:52 pmRNSDirector/PDMR Shareholding
4th May 201811:12 amRNSDirector/PDMR Shareholding and Issue of Equity
30th Apr 20187:00 amRNSTotal Voting Rights
9th Apr 20188:25 amRNSChange of Adviser
3rd Apr 20188:34 amRNSTotal Voting Rights
28th Mar 20187:00 amRNSInterim Results
26th Mar 201811:15 amRNSHolding(s) in Company
23rd Mar 20183:16 pmRNSHolding(s) in Company
2nd Mar 201812:11 pmRNSGrant of options
1st Mar 20187:00 amRNSTotal Voting Rights
28th Feb 20187:00 amRNSBlock listing Return
28th Feb 20187:00 amRNSListing Application
21st Feb 20183:08 pmRNSDirector/PDMR Shareholding
20th Feb 20187:00 amRNSTrading Update
8th Feb 20187:00 amRNSAdditional information regarding acquisitions
1st Feb 20188:00 amRNSIssue of Equity
1st Feb 20187:00 amRNSCompletion of Acquisitions
31st Jan 201812:16 pmRNSTotal Voting Rights
24th Jan 20182:20 pmRNSResult of AGM
2nd Jan 20188:50 amRNSTotal Voting Rights
30th Nov 20179:05 amRNSTotal Voting Rights
8th Nov 20177:00 amRNSAudited results for the year ended 31 July 2017
31st Oct 20179:09 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.